. Author manuscript; available in PMC: 2019 Apr 1.

Published in final edited form as: J Interv Cardiol. 2017 Dec 4;31(2):177–184. doi: 10.1111/joic.12462

Table II.

Angiographic characteristics

	Heparin (n=123)	Bivalirudin (n=137)	p-value
Left Ventricular Ejection Fraction (± SD)	52.4% (± 11.4)	56.6% (±10.7)	0.008
Access Site
Radial A.	35 (28.5%)	32 (23.7%)	0.392
Femoral A.	88 (71.5%)	105 (77.8%)	0.253
Closure device was used	62 (70.5%)^*	75 (71.4%)^*	0.447
Vessels Treated
Left Main	4 (3.3%)	9 (6.7%)	0.209
Left Anterior Descending	46 (37.4%)	65 (47.4%)	0.082
Left Circumflex	43 (35.0%)	44 (32.6%)	0.699
Right Coronary	42 (34.1%)	44 (32.6%)	0.802
Arterial and Venous Graft	9 (7.3%)	4 (3.0%)	0.355
Lesion Characteristics
Calcified Lesion	14 (11.4%)	15 (10.9%)	0.950
Tortuosity	7 (5.7%)	3 (2.2%)	0.151
Bifurcation	26 (21.1%)	36 (26.7%)	0.297
Drug-Eluting Stent	99 (80.5%)	116 (84.6%)	0.252

Note: Closure device percentage is derived from femoral access only.